Suki, an AI ambient scribe for clinicians, raises a $90M Series E
Partly confirmed
The takeaway
Axios reported on Oct 12, 2026 that Suki, which makes an AI assistant that listens to patient visits and writes clinical notes, raised a $90 million Series E led by Healthier Capital.
Status
- Claim
Partly confirmed
- Our reporting
- Medium confidence
- Importance
- 2 of 5
- Last verified
- 13 October 2026
Your AI and this story
- GPT-6 Astra165 days after its cutoff
- Claude Opus 5.5104 days after its cutoff
- Gemini 3.8 Flash195 days after its cutoff
- Grok 4.7134 days after its cutoff
None of these four assistants can know about it. The closest, Claude Opus 5.5, stops 104 days before it.
Key facts
- Round: $90M Series E, led by Healthier Capital (Axios, per Techmeme’s summary)
- Revenue: ‘a source says it projects $60M-$80M in revenue this year’ (Techmeme’s summary of Axios)
- Inc. also covered the round (‘Suki, a Siri for Doctors, Just Raised $90 Million’); its URL names Zoom Ventures, Philips Ventures and Hercules Capital, whose roles were not read
- Earlier funding: $70M Series D in October 2024 led by Hedosophia, bringing the total then to $165M (Business Wire)
What happened
Suki sells Suki Assistant, which listens to patient-clinician conversations and drafts clinical documentation, to health systems. The new round was first reported by Axios Pro.
Why it matters
Ambient scribes are among the few AI products with wide paid use in hospitals. A revenue projection of $60M to $80M gives a rare data point on the size of a second-tier vendor in that market.
Written from Techmeme’s headline summary and article titles only: Axios Pro and Inc. both blocked automated access. Valuation and the full investor list are not confirmed here.
Sources
3 sources from 3 sites. Numbers match the chips in the text.
3 sources: 1 primary, 2 press
Primary
- Business Wire: Suki Secures $70M Series D Funding (Oct 2024)businesswire.com, official
Press
Changes
- Filed (morning)